While many growth factor receptor pathways are activated in PCa progression (such as epidermal growth factor receptor (EGFR), ErbB2 (HER2/neu), and MET), ligands that drive activation of these pathways remain poorly defined. This evidence concerns the gene EGFR and posterior cortical atrophy.